Home
Home
Contact
Careers
Terms and Conditions
Privacy Policy
Cookie Policy
YouTube
X
LinkedIn
About Arcturus
RNA Medicines
Technologies
Pipeline
Clinical Trials
Business Development
Publications
Investor Relations

Lipid Nanoparticle Formulation Increases Efficiency of DNA-Vectored Vaccines/Immunoprophylaxis in Animals Including Transchromosomic Bovines

September 27, 2020

Home
Contact
Careers
Terms and Conditions
Privacy Policy
Cookie Policy
YouTube
X
LinkedIn
© 2026 Arcturus Therapeutics, Inc.